Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term effects of metformin in type 2 diabetes.
Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA. Eriksson A, et al. Among authors: eriksson jw. Diabetes Obes Metab. 2007 May;9(3):330-6. doi: 10.1111/j.1463-1326.2006.00611.x. Diabetes Obes Metab. 2007. PMID: 17391159 Clinical Trial.
Short-term effects of metformin in type 2 diabetes.
Eriksson A, Attvall S, Bonnier M, Eriksson JW, Rosander B, Karlsson FA. Eriksson A, et al. Among authors: eriksson jw. Diabetes Obes Metab. 2007 Jul;9(4):483-9. doi: 10.1111/j.1463-1326.2006.00624.x. Diabetes Obes Metab. 2007. PMID: 17587390 Clinical Trial.
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia.
Nyström T, Bodegard J, Nathanson D, Thuresson M, Norhammar A, Eriksson JW. Nyström T, et al. Among authors: eriksson jw. Diabetes Res Clin Pract. 2017 Jan;123:199-208. doi: 10.1016/j.diabres.2016.12.004. Epub 2016 Dec 19. Diabetes Res Clin Pract. 2017. PMID: 28056431 Free article.
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol.
Sundström J, Kristófi R, Östlund O, Bennet L, Eliasson B, Jansson S, Leksell J, Almby K, Lundqvist M, Eriksson JW; SMARTEST study group (see list in Appendix). Sundström J, et al. Among authors: eriksson jw. J Diabetes Complications. 2021 Oct;35(10):107996. doi: 10.1016/j.jdiacomp.2021.107996. Epub 2021 Jul 21. J Diabetes Complications. 2021. PMID: 34389234 Free article.
232 results